Drug recall
Red Blood Cells (Apheresis) Leukocytes Reduced.
FDA recall event 36011 · Class III · New York Blood Center, Inc.
Key facts
| Event ID | 36011 |
|---|---|
| Recall numbers | B-1810-6, B-1811-6 |
| Recalling firm | New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Red Blood Cells (Apheresis) Leukocytes Reduced., Red Blood Cells Leukocytes Reduced. |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, exposed to unacceptable shipping temperatures, were distributed. |
| Initiation date | Mar 10, 2004 |
| Termination date | Sep 19, 2006 |
| City | New York |
| Country | United States |
| FEI number | 2473015 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports